These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14707704)

  • 1. Pancytopenia due to suppressed hematopoiesis in a case of fatal hemolytic disease of the newborn associated with anti-K supported by molecular K1 typing.
    Wagner T; Resch B; Reiterer F; Gassner C; Lanzer G
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):13-5. PubMed ID: 14707704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First case of hemolytic disease of the newborn due to anti-Ula antibodies.
    Sakuma K; Suzuki H; Ohto H; Tsuneyama H; Uchikawa M
    Vox Sang; 1994; 66(4):293-4. PubMed ID: 8079454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin.
    Dhodapkar KM; Blei F
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):69-70. PubMed ID: 11196277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of hemolytic disease of the newborn infant due to anti-K (Cellano).
    Moncharmont P; Juron-Dupraz F; Doillon M; Vignal M; Debeaux P
    Acta Haematol; 1991; 85(1):45-6. PubMed ID: 2011931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-anti-D antibodies in red-cell alloimmunization.
    Moise KJ
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen.
    Scharberg EA; Wieckhusen C; Luz B; Rothenberger S; Stürzel A; Rink G; Richter E; Delle Chiaie L; Burgos A; Lomas-Francis C; Bugert P
    Transfusion; 2017 Jan; 57(1):217-218. PubMed ID: 27679424
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 8. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.
    Cro' F; Lapucci C; Vicari E; Salsi G; Rizzo N; Farina A
    Am J Reprod Immunol; 2016 Dec; 76(6):499-503. PubMed ID: 27730708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic disease of the newborn due to anti-Ku (author's transl)].
    Huang HJ; Tagawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
    Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
    Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Kell in pregnancy.
    Vaughan JI; Warwick R; Welch CR; Letsky EA
    Br J Obstet Gynaecol; 1991 Sep; 98(9):944-5. PubMed ID: 1911618
    [No Abstract]   [Full Text] [Related]  

  • 14. Kell sensitization in pregnancy.
    Caine ME; Mueller-Heubach E
    Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolytic disease of the newborn due to anti-K antibodies.
    de Jonge N; Martens JE; Milani AL; Krijnen JL; van Krimpen C; Ponjee GA
    Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):69-72. PubMed ID: 8789754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hemolytic disease of the newborn due to anti-Js(b).
    Gordon MC; Kennedy MS; O'Shaughnessy RW; Waheed A
    Vox Sang; 1995; 69(2):140-1. PubMed ID: 8585197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kell expression on myeloid progenitor cells.
    Wagner T; Lanzer G; Geissler K
    Leuk Lymphoma; 2002 Mar; 43(3):479-85. PubMed ID: 12002749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-K antibodies in pregnant women and genotyping of K antigen in foetuses].
    Zupańska B; Nowaczek-Migas M; Michalewska B; Wielgoś M; Orzińska A
    Ginekol Pol; 2008 Jun; 79(6):410-4. PubMed ID: 18652128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.